D-Index & Metrics Best Publications
Brian D. Johnston

Brian D. Johnston

University of Minnesota
United States

Overview

What is he best known for?

The fields of study he is best known for:

  • Bacteria
  • Antibiotics
  • Gene

His main research concerns Microbiology, Escherichia coli, Antibiotic resistance, Virulence and Molecular epidemiology. His Microbiology study incorporates themes from Pulsed-field gel electrophoresis, Genotype and Genetics. In Genotype, he works on issues like Cephalosporin, which are connected to Sulfamethoxazole and Feces.

His Escherichia coli research incorporates elements of Multiple drug resistance and Polymerase chain reaction. His research integrates issues of Bacteremia, Ciprofloxacin, Gentamicin and Veterans Affairs in his study of Multiple drug resistance. He works mostly in the field of Virulence, limiting it down to concerns involving Enterobacteriaceae and, occasionally, Amplified fragment length polymorphism, CATS and Virology.

His most cited work include:

  • The Epidemic of Extended-Spectrum-β-Lactamase-Producing Escherichia coli ST131 Is Driven by a Single Highly Pathogenic Subclone, H30-Rx (314 citations)
  • Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004 (244 citations)
  • Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004 (244 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Escherichia coli, Microbiology, Virulence, Genotype and Antibiotic resistance. His Escherichia coli research is multidisciplinary, relying on both Multiple drug resistance, Molecular epidemiology and Multilocus sequence typing. The study incorporates disciplines such as Polymerase chain reaction, Pulsed-field gel electrophoresis and Virology in addition to Microbiology.

His studies deal with areas such as Genotyping, Serotype and Enterobacteriaceae as well as Virulence. The study incorporates disciplines such as Broth microdilution and Ceftazidime/avibactam in addition to Genotype. Trimethoprim is closely connected to Sulfamethoxazole in his research, which is encompassed under the umbrella topic of Antibiotic resistance.

He most often published in these fields:

  • Escherichia coli (116.96%)
  • Microbiology (113.39%)
  • Virulence (66.07%)

What were the highlights of his more recent work (between 2017-2021)?

  • Escherichia coli (116.96%)
  • Microbiology (113.39%)
  • Virulence (66.07%)

In recent papers he was focusing on the following fields of study:

Escherichia coli, Microbiology, Virulence, Genotype and Extraintestinal Pathogenic Escherichia coli are his primary areas of study. His Escherichia coli study combines topics in areas such as Treatment outcome, Illness severity, Antibiotic resistance and Diarrhea. His study looks at the relationship between Microbiology and fields such as Ceftazidime/avibactam, as well as how they intersect with chemical problems.

His research integrates issues of Bacteremia, Clade and Multilocus sequence typing in his study of Virulence. Brian D. Johnston studied Genotype and Multiple drug resistance that intersect with Gentamicin and Levofloxacin. His Extraintestinal Pathogenic Escherichia coli study combines topics from a wide range of disciplines, such as Phylogenetics and Phylogenetic tree.

Between 2017 and 2021, his most popular works were:

  • Phylogenomic Analysis of Extraintestinal Pathogenic Escherichia coli Sequence Type 1193, an Emerging Multidrug-Resistant Clonal Group. (20 citations)
  • Rapid Emergence, Subsidence, and Molecular Detection of Escherichia coli Sequence Type 1193-fimH64, a New Disseminated Multidrug-Resistant Commensal and Extraintestinal Pathogen. (19 citations)
  • Accessory Traits and Phylogenetic Background Predict Escherichia coli Extraintestinal Virulence Better Than Does Ecological Source. (17 citations)

In his most recent research, the most cited papers focused on:

  • Bacteria
  • Gene
  • Antibiotics

Brian D. Johnston focuses on Escherichia coli, Extraintestinal Pathogenic Escherichia coli, Virulence, Microbiology and Gene. His study in Antibiotic resistance extends to Escherichia coli with its themes. He has researched Virulence in several fields, including Pathogen, Molecular epidemiology, Genotype and Multiple drug resistance.

His work on Pulsed-field gel electrophoresis as part of general Genotype study is frequently connected to Context, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Brian D. Johnston works mostly in the field of Microbiology, limiting it down to concerns involving Enterobacteriaceae and, occasionally, Cefotaxime, Bacteria, Imipenem and Ciprofloxacin. His biological study spans a wide range of topics, including Lineage, Genome, Sequence analysis and Plasmid.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Epidemic of Extended-Spectrum-β-Lactamase-Producing Escherichia coli ST131 Is Driven by a Single Highly Pathogenic Subclone, H30-Rx

Lance B. Price;Lance B. Price;James R. Johnson;Maliha Aziz;Maliha Aziz;Connie Clabots.
Mbio (2013)

399 Citations

Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004

James R. Johnson;James R. Johnson;Megan Menard;Megan Menard;Brian Johnston;Brian Johnston;Michael A. Kuskowski;Michael A. Kuskowski.
Antimicrobial Agents and Chemotherapy (2009)

387 Citations

Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004.

James R. Johnson;Mark R. Sannes;Cynthia Croy;Brian Johnston.
Emerging Infectious Diseases (2007)

312 Citations

Extended-Spectrum β-Lactamase–Producing Escherichia coli From Retail Chicken Meat and Humans: Comparison of Strains, Plasmids, Resistance Genes, and Virulence Factors

Jan A. J. W. Kluytmans;Ilse T. M. A. Overdevest;Ina Willemsen;Marjolein F. Q. Kluytmans-van den Bergh.
Clinical Infectious Diseases (2013)

300 Citations

Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli

James R Johnson;Veronika Tchesnokova;Brian D Johnston;Connie Clabots.
The Journal of Infectious Diseases (2013)

292 Citations

Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans

Aylin Colpan;Brian Johnston;Brian Johnston;Stephen Porter;Connie Clabots.
Clinical Infectious Diseases (2013)

204 Citations

Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts.

Ritu Banerjee;Brian D Johnston;Christine Lohse;Stephen B. Porter.
Infection Control and Hospital Epidemiology (2013)

175 Citations

Sepsis From the Gut: The Enteric Habitat of Bacteria That Cause Late-Onset Neonatal Bloodstream Infections

Mike A. Carl;I. Malick Ndao;A. Cody Springman;Shannon D. Manning.
Clinical Infectious Diseases (2014)

170 Citations

Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010

Ritu Banerjee;Ari Robicsek;Michael A. Kuskowski;Stephen Porter.
Antimicrobial Agents and Chemotherapy (2013)

150 Citations

Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25: H4) and bla CTX-M-15among extended-spectrum-β- lactamase-producing E. coli from the United States, 2000 to 2009

James R. Johnson;James R. Johnson;Carl Urban;Carl Urban;Scott J. Weissman;James H. Jorgensen.
Antimicrobial Agents and Chemotherapy (2012)

150 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Brian D. Johnston

James R. Johnson

James R. Johnson

University of Minnesota

Publications: 100

Mark A. Schembri

Mark A. Schembri

University of Queensland

Publications: 37

David L. Paterson

David L. Paterson

University of Queensland

Publications: 34

Lance B. Price

Lance B. Price

George Washington University

Publications: 31

Jorge Blanco

Jorge Blanco

University of Santiago de Compostela

Publications: 29

Olivier Clermont

Olivier Clermont

Université Paris Cité

Publications: 29

Erick Denamur

Erick Denamur

Université Paris Cité

Publications: 28

Johann D. D. Pitout

Johann D. D. Pitout

University of Calgary

Publications: 27

Jesús Rodríguez-Baño

Jesús Rodríguez-Baño

University of Seville

Publications: 27

Scott A. Beatson

Scott A. Beatson

University of Queensland

Publications: 27

Jan Kluytmans

Jan Kluytmans

Utrecht University

Publications: 23

Azucena Mora

Azucena Mora

University of Santiago de Compostela

Publications: 23

Darren J. Trott

Darren J. Trott

University of Adelaide

Publications: 22

Anette M. Hammerum

Anette M. Hammerum

Statens Serum Institut

Publications: 21

Jukka Corander

Jukka Corander

University of Oslo

Publications: 21

Álvaro Pascual

Álvaro Pascual

University of Seville

Publications: 20

Trending Scientists

Ramakrishnan Ramanathan

Ramakrishnan Ramanathan

University of Essex

G. Geoffrey Booth

G. Geoffrey Booth

Michigan State University

Thomas Villmann

Thomas Villmann

Hochschule Mittweida

Guofan Jin

Guofan Jin

Tsinghua University

Richard F. Lyon

Richard F. Lyon

Google (United States)

Rafael Luque

Rafael Luque

University of Córdoba

K. H. Andy Choo

K. H. Andy Choo

Royal Children's Hospital

Michael D. Swaine

Michael D. Swaine

University of Aberdeen

Andrea Quaroni

Andrea Quaroni

Cornell University

Nora Heisterkamp

Nora Heisterkamp

Children's Hospital of Los Angeles

Jeroen Raes

Jeroen Raes

KU Leuven

Dan Smale

Dan Smale

National Institute of Water and Atmospheric Research

Susana Martinez-Conde

Susana Martinez-Conde

SUNY Downstate Medical Center

David L. Sparks

David L. Sparks

Baylor College of Medicine

Sonja Perren

Sonja Perren

University of Konstanz

Karlen Lyons-Ruth

Karlen Lyons-Ruth

Harvard University

Something went wrong. Please try again later.